TNF and Hepatic fibrosis: Based on the results, VSC-CDs in various dosage groups significantly diminish the levels of TNF-α, IL-6, and IL-1β, signifying that VSC-CDs inhibit the inflammatory response and thereby alleviate liver fibrosis.